Health Condition 1: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients of both the sex and age between 20-70 years.2.Naive patients or newly diagnosed patients of Hyperuricemia.3.Patients having serum uric acid more than 6.9mg/dl.4. Patients of Hyperuricemia with Gouty Arthritis.5.Patient recently diagnosed with uncomplicated Hyperuricemia & Gouty Arthritis.6.Hyperuricemic patients suffering from controlled hypertension, diabetes mellitus, CKD upto stage 3.
Exclusion criteria
Exclusion criteria: 1.Asymptomatic patient with Hyperuricemia. 2.Patients suffering from the complications of Hyperuricemia & Gouty Arthritis. 3.Pregnant and lactating women. 4.Presence of disease like CA, HIV, malignant hypertension, uncontrolled diabetes. 5. Patients suffering from major systemic illness or under long term drug treatment. 6.History of hypersensitivity to any of the trial drugs or their ingredients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To asses the effectiveness of SIMHASYADI KWATHA in management of symptomatology of Hyperuricemia.Timepoint: 45 days | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the effect of SIMHASYADI KWATHA and FEBUXOSTAT on serum uric acid level parameter.Timepoint: 30, 45 and 60 days | — |
Countries
India
Contacts
Govt Ayurvedic College and Hospital Guwahati